申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US20150018547A1
公开(公告)日:2015-01-15
The present invention provides a compound having a GOAT inhibitory action, which is useful for the prophylaxis or treatment of obesity and the like, and has superior efficacy. The present invention is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
本发明提供了一种具有GOAT抑制作用的化合物,该化合物可用于预防或治疗肥胖等疾病,并具有优越的疗效。该化合物由式(I)表示,其中每个符号如规范中所定义,或其盐。